Showing results (161-170 of 266) with videos related to

Sort By:
Pageof 27
Scientific Reports|December 1, 2022
Integrin beta1 (ITGB1) as a prognostic marker in esophageal adenocarcinomaAlexander I Damanakis, Isabell Wahler, Hans Fuchs, et al.
Annals of Surgical Oncology|April 11, 2022
Long-Term Outcome After Histopathological Complete Response with and Without Nodal Metastases Following Multimodal Treatment of Esophageal CancerWolfgang Schroeder, Markus P H Ghadimi, Hans Schloesser, et al.
Molecules (Basel, Switzerland)|September 2, 2020
Influence of the Molecular Weight and the Presence of Calcium Ions on the Molecular Interaction of Hyaluronan and DPPCThomas Zander, Vasil M Garamus, Andra Dédinaité, et al.
Clinical Nuclear Medicine|October 3, 2012
Tumor lesion glycolysis and tumor lesion proliferation for response prediction and prognostic differentiation in patients with advanced non-small cell lung cancer treated with erlotinibDeniz Kahraman, Arne Holstein, Matthias Scheffler, et al.
Scientific Reports|October 28, 2020
Integrin alpha V (ITGAV) expression in esophageal adenocarcinoma is associated with shortened overall-survivalHeike Loeser, Matthias Scholz, Hans Fuchs, et al.
Scientific Reports|August 7, 2025
The expression of the tight junction protein and therapeutical target Claudin 18.2 is heterogeneously distributed within esophageal and gastric adenocarcinomaSvetlana Pak, Adrian Georg Simon, Su Ir Lyu, et al.
The Oncologist|January 10, 2013
Interleukin-10 gene polymorphisms are associated with freedom from treatment failure for patients with Hodgkin lymphomaNils Schoof, Jeremy Franklin, Robert Fürst, et al.
Cancer Research|May 14, 2009
Cancer vaccine enhanced, non-tumor-reactive CD8(+) T cells exhibit a distinct molecular program associated with "division arrest anergy"Marc Beyer, Julia Karbach, Michael R Mallmann, et al.
Molecular and Clinical Oncology|August 8, 2017
Somatic BRCA1-associated protein 1 (BAP1) loss is an early and rare event in esophageal adenocarcinomaHeike Loeser, Dirk Waldschmidt, Fabian Kuetting, et al.
Blood|July 24, 2007
RNA fingerprints provide direct evidence for the inhibitory role of TGFbeta and PD-1 on CD4+ T cells in Hodgkin lymphomaJens M Chemnitz, Daniela Eggle, Julia Driesen, et al.
Pageof 27